Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2557Source: DataRank Database

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms is a research paper published in Clinical Pharmacology & Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 335 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access335 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 59.42)OA: bronzeTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Mikko Niemi ORCID,Laura B. Ramsey ORCID,Jasmine A. Luzum ORCID,E. Katriina Tarkiainen,Robert J. Straka ORCID

Live enrichment

PubMed:35152405 PMC:PMC9035072 OpenAlex:https://openalex.org/W4213127162

National Institutes of Health

Grant: R24GM115264

National Institutes of Health

Grant: U24HG010135

H2020 European Research Council

Grant: 725249

Individualizing statin therapy by using a systems pharmacology decision support algorithm

NHLBI NIH HHS

Grant: K08 HL146990

NIGMS NIH HHS

Grant: R24 GM061374

NHLBI NIH HHS

Grant: K23 HL143161

NIGMS NIH HHS

Grant: R01 GM117163

NHGRI NIH HHS

Grant: U01 HG007269

NIGMS NIH HHS

Grant: P50 GM115318

NHGRI NIH HHS

Grant: U24 HG010615

National Institutes of Health

Grant: 5K08HL146990-03

Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy

National Institutes of Health

Grant: 5U24HG010135-03

Clinical Pharmacogenetics Implementation Consortium (CPIC)

National Institutes of Health

Grant: 5U24HG010615-02

PharmGKB: pharmacogenomics discovery and implementation

National Institutes of Health

Grant: 1R24GM115264-01

Clinical Pharmacogenetics Implementation Consortium (CPIC)

National Institutes of Health

Grant: 5R24GM061374-13

PharmGKB: From Association to Mechanism

National Institutes of Health

Grant: 5R01GM117163-03

Discovery of Pharmacogenomic Biomarkers for Metformin Response

National Institutes of Health

Grant: 5P50GM115318-03

Pharmacogenomics of Statin Therapy

National Institutes of Health

Grant: 5U01HG007269-02

Genomic Medicine Implementation: The Personalized Medicine Program

FWCI

59.42

Citation Percentile

1.0%

Citation Trend

2017

2022

2023

2024

2025

2026

bronzeLicense: Wiley Online Library User Agreement

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2557

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2557

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2557

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.2557

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2557

Fields of Study

Lipoproteins and Cardiovascular HealthDrug Transport and Resistance MechanismsInflammatory mediators and NSAID effects0301 basic medicine03 medical and health sciences0303 health sciencesATP Binding Cassette Transporter, Subfamily G, Member 2Cytochrome P-450 CYP2C9GenotypeHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLiver-Specific Organic Anion Transporter 1Neoplasm ProteinsPharmacogeneticsRosuvastatin CalciumSimvastatin

MeSH Terms

Rosuvastatin CalciumATP Binding Cassette Transporter, Subfamily G, Member 2GenotypeHumansNeoplasm ProteinsPharmacogeneticsHydroxymethylglutaryl-CoA Reductase InhibitorsSimvastatinLiver-Specific Organic Anion Transporter 1Cytochrome P-450 CYP2C9

Keywords

SLCO1B1RosuvastatinStatinPharmacogeneticsMedicinePharmacologyPitavastatinFluvastatinRosuvastatin CalciumAtorvastatinPharmacogenomicsCYP2C9Internal medicineGenotypeSimvastatinBiologyCytochrome P450GeneticsMember 2ATP Binding Cassette TransporterCardiovascularSubfamily GPharmacy and PharmacologyClinical ResearchHealth SciencesATP Binding Cassette Transporter, Subfamily G, Member 2HumansPharmacology & PharmacyCytochrome P-450 CYP2C9Liver-Specific Organic Anion Transporter 1Evaluation of treatments and therapeutic interventionsPharmacology and Pharmaceutical SciencesNeoplasm ProteinsGood Health and Well Being6.1 PharmaceuticalsPatient SafetyHydroxymethylglutaryl-CoA Reductase Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being